cis-Chlordane (CED0000042)

Record Information
Version1.0
Creation Date2009-03-06 18:58:00 UTC
Update Date2026-04-05 10:22:18 UTC
Accession NumberCHEM000055
Identification
Common Namecis-Chlordane
ClassSmall Molecule
Description
cis-Chlordane is an exogenous organic compound with the formula C10H6Cl8 and an average molecular weight of 409.78 g/mol. It exists as a liquid at room temperature. cis-Chlordane belongs to the vinyl chlorides, a subclass of vinyl halides within the organic compounds. The compound has been found in or released from food, food processing, and cookware food contact materials, with recorded exposure routes including inhalation, oral, and touch. cis-Chlordane interacts with thirteen recorded protein targets. It inhibits alkaline phosphatases in renal and hepatic tissues, specifically targeting the tissue-nonspecific isozyme of alkaline phosphatase (ALPL). It induces hepatic cytochrome P-450, including CYP2B6, CYP3A4, CYP3A43, and CYP3A5, which causes hepatocellular hypertrophy and a large increase in the volume of the smooth endoplasmic reticulum. Furthermore, cis-Chlordane causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor (ESR1 and ESR2). It antagonizes estrogen-related receptors, affecting transcription through ESRRG, ESRRA, and ESRRB. Developmental defects are caused by the binding and activation of retinoic acid receptor beta (RARB) and retinoic acid receptor gamma (RARG). Additionally, cis-Chlordane is believed to bind irreversibly to DNA, which leads to altered cellular function or cell death.
Contaminant Type
  • Organic Compound
  • Organochloride
  • Pesticide
  • Synthetic Compound
Chemical Structure
SynonymsNot Available
Chemical FormulaC10H6Cl8
Average Molecular Mass409.779 g/mol
Monoisotopic Mass405.798 g/mol
CAS Registry Number5103-71-9
IUPAC Name(1R,3R,4S,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.0²,⁶]dec-8-ene
Traditional Name(1R,3R,4S,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.0²,⁶]dec-8-ene
SMILES[H][C@]1(Cl)CC2([H])C([H])([C@@]1([H])Cl)[C@@]1(Cl)C(Cl)=C(Cl)[C@]2(Cl)C1(Cl)Cl
InChI IdentifierInChI=1S/C10H6Cl8/c11-3-1-2-4(5(3)12)9(16)7(14)6(13)8(2,15)10(9,17)18/h2-5H,1H2/t2?,3-,4?,5-,8-,9+/m0/s1
InChI KeyBIWJNBZANLAXMG-MRAITHJBSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as vinyl chlorides. These are vinyl halides in which a chlorine atom is bonded to an sp2-hybridised carbon atom.
KingdomOrganic compounds
Super ClassOrganohalogen compounds
ClassVinyl halides
Sub ClassVinyl chlorides
Direct ParentVinyl chlorides
Alternative Parents
Substituents
  • Chloroalkene
  • Haloalkene
  • Vinyl chloride
  • Hydrocarbon derivative
  • Organochloride
  • Alkyl halide
  • Alkyl chloride
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External DescriptorsNot Available
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateLiquid
AppearanceColorless to amber liquid.
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
Solubility5.6e-05 mg/mL at 25 °C [MABEY,WR et al. (1981)]
Predicted Properties
PropertyValueSource
Water Solubility6.9e-05 g/LALOGPS
logP6.02ALOGPS
logP5.27ChemAxon
logS-6.8ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity80.38 m³·mol⁻¹ChemAxon
Polarizability32.55 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0001900000-cbe0d008d48efeebddc7Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0004900000-b9d20b4f44fa679d7984Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-2119000000-8e3e670086348c43ae15Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-0001900000-11a7620b8bbb40ee8c05Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0gb9-0009400000-73bfd1e73d846959f213Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0159-1009000000-3ce6dcfd1ccf213fc417Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityChlordane is believed to bind irreversibly to DNA, leading to cell death or altered cellular function. It also affects transcription by antagonizing estrogen-related receptors. Chlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. Chlordane has also been shown to bind and activate retinoic acid receptor, causing various developmental defects, and inhibit alkaline phosphatases in hepatic and renal tissues. (7, 1, 2, 3, 4)
Carcinogenicity (IARC Classification)Chlordane is possibly carcinogenic to humans (Group 2B). (9)
Minimum Risk LevelIntermediate Inhalation: 0.0002 mg/m3 (8) Chronic Inhalation: 0.00002 mg/m3 (8) Acute Oral: 0.001 mg/kg/day (8) Intermediate Oral: 0.0006 mg/kg/day (8) Chronic Oral: 0.0006 mg/kg/day (8)
SymptomsIngestion and inhalation of chlordane cause headaches, irritability, confusion, weakness, vision problems, vomiting, stomach cramps, diarrhea, and jaundice. (7)
TreatmentTreatment is symptomatic. It is aimed at controlling convulsions, coma, and respiratory depression. Gastric lavage, followed by the administration of activated charcoal, may be performed following ingestion. (10)
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
200.0mg/kgNot AvailableRatLD50OralexperimentalT13
343.0mg/kgNot AvailableRatLD50IntraperitonealexperimentalT13
10.0mg/kgNot AvailableMouseLD50IntravenousexperimentalT14
780.0mg/kgNot AvailableRatLD50DermalexperimentalT14
100.0mg/m3Not AvailableCatLC50Inhalation (4 hours)experimentalT14
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
494Food contact materialsFood, food processing & cookwareNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
histidine kinase structureClick to view 3D structurehistidine kinaseO32393Arthrospira platensisPredicted (SEA)0.233548
Click to view 3D structureGABA receptor subunitQ75NA5Musca domesticaPredicted (SEA)0.0778492
Gamma-aminobutyric acid receptor subunit beta-3 structureClick to view 3D structureGamma-aminobutyric acid receptor subunit beta-3P28472HumansPredicted (SEA)1.01204
Gamma-aminobutyric acid receptor subunit rho-1 structureClick to view 3D structureGamma-aminobutyric acid receptor subunit rho-1P24046HumansPredicted (SEA)98.3236
Cytochrome P450 2C19 structureClick to view 3D structureCytochrome P450 2C19P33261HumansPredicted (SEA)7767.09
Amine oxidase [flavin-containing] B structureClick to view 3D structureAmine oxidase [flavin-containing] BP27338HumansPredicted (SEA)7677.72
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)7676.48
Click to view 3D structureSodium-dependent dopamine transporterP23977Rattus norvegicusPredicted (SEA)7578.7
WD repeat-containing protein 91 structureClick to view 3D structureWD repeat-containing protein 91A4D1P6HumansPredicted (SEA)2591.44
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)7767.33
Amine oxidase [flavin-containing] A structureClick to view 3D structureAmine oxidase [flavin-containing] AP21397HumansPredicted (SEA)7713.85
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)7772.31
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)7770.91
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)7777.68
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)7778.93
Cytochrome P450 1A2 structureClick to view 3D structureCytochrome P450 1A2P05177HumansPredicted (SEA)7772.47
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)7778.69
Click to view 3D structureKynurenine 3-monooxygenaseP38169Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)Predicted (SEA)1755.42
Lysine-specific histone demethylase 1A structureClick to view 3D structureLysine-specific histone demethylase 1AO60341HumansPredicted (SEA)7664.41
Click to view 3D structureSigma non-opioid intracellular receptor 1Q60492Cavia porcellusPredicted (SEA)7716.96
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)7770.83
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)7776.83
Click to view 3D structureTransporterQ63380Rattus norvegicusPredicted (SEA)7318.45
Cytochrome P450 2B6 structureClick to view 3D structureCytochrome P450 2B6P20813HumansPredicted (SEA)7754.41
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)7780.02
Cytochrome P450 2B6 structureClick to view 3D structureCytochrome P450 2B6P20813HumansKnownChlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. (L91, A68)
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansKnownChlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. (L91, A68)
Click to view 3D structureCytochrome P450 3A43Q9HB55HumansKnownChlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. (L91, A68)
Cytochrome P450 3A5 structureClick to view 3D structureCytochrome P450 3A5P20815HumansKnownChlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. (L91, A68)
Cytochrome P450 3A7 structureClick to view 3D structureCytochrome P450 3A7P24462HumansKnownChlordane induces hepatic cytochrome P-450, causing a large increase in the volume of the smooth endoplasmic reticulum, which results in hepatocellular enlargement and hypertrophy. (L91, A68)
Estrogen receptor structureClick to view 3D structureEstrogen receptorP03372HumansKnownCauses endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590)
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansKnownCauses endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590)
Alkaline phosphatase, tissue-nonspecific isozyme structureClick to view 3D structureAlkaline phosphatase, tissue-nonspecific isozymeP05186HumansKnownChlordane inhibit alkaline phosphatases in hepatic and renal tissues. (A69)
Estrogen-related receptor gamma structureClick to view 3D structureEstrogen-related receptor gammaP62508HumansKnownChlordane affects transcription by antagonizing estrogen-related receptors. (A52)
Retinoic acid receptor beta structureClick to view 3D structureRetinoic acid receptor betaP10826HumansKnownChlordane has been shown to bind and activate retinoic acid receptor, causing various developmental defects. (A53)
Retinoic acid receptor gamma structureClick to view 3D structureRetinoic acid receptor gammaP13631HumansKnownChlordane has been shown to bind and activate retinoic acid receptor, causing various developmental defects. (A53)
Steroid hormone receptor ERR1 structureClick to view 3D structureSteroid hormone receptor ERR1P11474HumansKnownChlordane affects transcription by antagonizing estrogen-related receptors. (A52)
Steroid hormone receptor ERR2 structureClick to view 3D structureSteroid hormone receptor ERR2O95718HumansKnownChlordane affects transcription by antagonizing estrogen-related receptors. (A52)
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkNot Available
Chemspider IDNot Available
ChEBI IDNot Available
PubChem Compound ID12303021
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References